Phosphinic peptide matrix metalloproteinase-9 inhibitors by solid-phase synthesis using a building block approach

Chemistry - A European Journal

Volumn 5, Issue 10, 1999, Pages 2877-2884

  Buchardt, Jens ^a   Ferreras, Mercedes ^b   Krog Jensen, Christian ^a   Delaissé, Jean Marie ^b   Foged, Niels Tækker ^b   Meldal, Morten ^a  

^a CARLSBERG LABORATORY   (Denmark)

^b CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

Author keywords

Enzyme inhibitors; Matrix metalloproteinases; Peptide isosters; Solid phase synthesis

Indexed keywords

GELATINASE INHIBITOR; MATRIX METALLOPROTEINASE INHIBITOR; PHOSPHINIC ACID DERIVATIVE;

AMINO ACID ANALYSIS; ARTICLE; DECOMPOSITION; DRUG SYNTHESIS; ENZYME MECHANISM; ENZYME SPECIFICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROTEIN PURIFICATION; REACTION ANALYSIS; SOLID STATE;

EID: 0032868884     PISSN: 09476539     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-3765(19991001)5:10<2877::AID-CHEM2877>3.0.CO;2-Z     Document Type: Article

References (83)

1. 2-.
2. H. Nagase, "Matrix Metalloproteinases" in Zinc Metalloproteases in Health and Disease (Ed.: N. M. Hooper), Taylor and Francis, London, 1996, pp. 153-204.
3. H. Birkedal-Hansen, W. G. I. Moore, M. K. Bodden, L. J. Windsor, B. Birkedal-Hansen, A. DeCarlo, J. A. Engler, Crit. Rev. Oral Bio. Med. 1993, 4, 197-250.
4. J. A. Lorenzo, C. C. Pilbeam, J. F. Kalinowski, M. S. Hibbs, Matrix 1992, 12, 282-290.
5. J.-M. Delaissé, G. Vaes, Mechanism of Mineral Solubilization and Matrix Degradation in Osteoclastic Bone Resorption, in Biology and Physiology of the Osteoclasts (Eds.: B. R. Rifkin, C. V. Gay), CRC Press, 1992, pp. 289-314.
6. H. Peng, I. Byrjalsen, M. Ferreras, N. T. Foged, J.-M. Delaissé, Bone 1998, 23, S552.
7. J.-M. Delaissé, Y. Eeckhout, G. Vaes, Biochem. Biophys. Res. Commun. 1984, 125, 441-447.
8. V. Everts, J.-M. Delaissé, W. Korper, W. Beertsen, J. Bone Miner. Res. 1998, 13, 1420-1430.
9. T. Sato, M. C. Ovejero, P. Hou, A.-M. Heegaard, M. Kumegawa, N. T. Foged, J.-M. Delaissé, J. Cell Sci. 1997, 110, 589-596.
10. J.-M. Delaissé, Y. Eeckhout, C. Francois-Gillet, P. Henriet, Y. Su, G. Vaes, R. Baron, J. Cell Sci. 1993, 106, 1071-1082.
11. K. Tezuka, K. Nemoto, Y. Tezuka, T. Sato, Y. Ikeda, M. Kobori, H. Kawashima, H. Egushi, Y. Hakeda, M. Kumegawa, J. Biol. Chem. 1994, 269, 15006-15009.
12. P. Reponen, C. Sahlberg, C. Munaut, I. Thesleff, K. Tryggvason, J. Cell Biol. 1994, 124, 1091-1102.
13. Y. Okada, K. Naka, K. Kawamura, T. Matsumoto, I. Nakanishi, N. Fujimoto, H. Sato, M. Seiki, Lab. Invest. 1995, 72, 1-12.
14. Also referred to membrane-type 1 MMP (MT1-MMP)
15. L. Blavier, J.-M. Delaissé, J. Cell Sci. 1995, 108, 3649-3659.
16. T. Sato, N. T. Foged, J.-M. Delaissé, J. Bone Miner. Res. 1998, 13, 59-66.
17. S. Netzel-Arnett, Q.-X. Sang, W. G. I. Moore, M. Navre, H. Birkedal-Hansen, H. E. Van Wart, Biochemistry 1993, 32, 6427-6432.
18. C. G. Knight, F. Willenbrock, G. Murphy, FEBS Lett. 1992, 296, 263-266.
19. Bachem catalogue 1999, D11, product No. M-1895; Mca: (7-methoxycoumarin-4-yl)acetyl, Dpa: N-3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl.
20. -indicates the preferred cleavage site for MMPs throughout the article.
21. M. Renil, M. Ferreras, J.-M. Delaissé, N. T. Foged, M. Meldal, J. Pept. Sci. 1998, 4, 195-210.
22. J. Lloyd, J. B. Schmidt, J. T. Hunt, J. C. Barrish, D. K. Little, A. A. Tymiak, Bioorg. Med. Chem. Lett. 1996, 6, 1323-1326.
23. W. H. Parsons, A. A. Patchett, H. G. Bull, W. R. Schoen, D. Taub, J. Davidson, P. L. Combs, J. P. Springer, H. Gadebusch, B. Weissberger, M. E. Valiant, T. N. Mellin, R. D. Busch, J. Med. Chem. 1988, 31, 1772-1778.
24. B. A. Ellsworth, N. J. Tom, P. A. Bartlett, Chem. Biol. 1996, 3, 37-44.
25. R. E. Galardy, D. Grobelny, Z. P. Kortylewicz, L. Poncz, Matrix 1992, 259-262.
26. D. Grobelny, U. B. Goli, R. E. Galardy, Biochemistry 1989, 28, 4948-4951.
27. B. P. Morgan, J. M. Scholtz, M. D. Ballinger, I. D. Zipkin, P. A. Bartlett, J. Am. Chem. Soc. 1991, 113, 297-307.
28. J. L. Goulet, J. F. Kinneary, P. L. Durette, R. L. Stein, R. K. Harrison, M. Izquierdo-Martin, D. W. Kuo, T.-Y. Lin, W. K. Hagmann, Bioorg. Med. Chem. Lett. 1994, 4, 1221-1224.
29. S. A. Bernhard, L. E. Orgel, Science 1959, 130, 625-626.
30. N. E. Jacobsen, P. A. Bartlett, J. Am. Chem. Soc. 1981, 103, 654-657.
31. P. A. Bartlett, C. K. Marlowe, Biochemistry 1983, 22, 4618-4624.
32. P. A. Bartlett, W. B. Kezer, J. Am. Chem. Soc. 1984, 106, 4282-4283.
33. K. A. Mookhtiar, C. K. Marlowe, P. A. Bartlett, H. E. Van Wart, Biochemistry 1987, 26, 1962-1965.
34. P. P. Giannousis, P. A. Bartlett, J. Med. Chem. 1987, 30, 1603-1609.
35. C. G. Caldwell, S. P. Sahoo, S. A. Polo, R. R. Eversole, T. J. Lanza, S. G. Mills, L. M. Niedzwiecki, M. Izquierdo-Martin, B. C. Chang, R. K. Harrison, D. W. Kuo, T.-Y. Lin, R. L. Stein, P. L. Durette, W. K. Hagmann, Bioorg. Med. Chem. Lett. 1996, 6, 323-328.
36. P. Jouin, J. Coste, N. Galeotti, J.-M. Campagne, P. Bedos, L. Guillou, Lett. Pept. Sci. 1995, 2, 233-238.
37. A. Yiotakis, A. Lecoq, S. Vassiliou, I. Raynal, P. Cuniasse, V. Dive, J. Med. Chem. 1994, 37, 2713-2720.
38. A. Yiotakis, A. Lecoq, A. Nicolaou, J. Labadie, V. Dive, Biochem. J. 1994, 303, 323-327.
39. J. Jirácek, A. Yiotakis, B. Vincent, A. Lecoq, A. Nicolaou, F. Checler, V. Dive, J. Biol. Chem. 1995, 270, 21701-21706.
40. J. Jirácek, A. Yiotakis, B. Vincent, F. Checler, V. Dive, J. Biol. Chem. 1996, 271, 19606-19611.
41. B. A. McKittrick, A. W. Stamford, X. Weng, K. Ma, S. Chackalamannil, M. Czarniecki, R. M. Cleven, A. B. Fawzi, Bioorg. Med. Chem. Lett. 1996, 6, 1629-1634.
42. A. Peyman, K.-H. Budt, J. Spanig, D. Ruppert, Angew. Chem. 1993, 105, 1852-1854; Angew. Chem. Int. Ed. Engl. 1993, 32, 1720-1722.
43. A. Peyman, K.-H. Budt, J. Spanig, D. Ruppert, Angew. Chem. 1993, 105, 1852-1854; Angew. Chem. Int. Ed. Engl. 1993, 32, 1720-1722.
44. D. Grobelny, E. M. Wondrak, R. E. Galardy, S. Oroszlan, Biochem. Biophys. Res. Commun. 1990, 169, 1111-1116.
45. M. C. Allen, W. Fuhrer, B. Tuck, R. Wade, J. M. Wood, J. Med. Chem. 1989, 32, 1652-1661.
46. P. A. Bartlett, J. E. Hanson, P. P. Giannousis, J. Org. Chem. 1990, 55, 6268-6274.
47. M. E. Tanner, S. Vaganay, J. van Heijenoort, D. Blanot, J. Org. Chem. 1996, 61, 1756-1760.
48. D. J. Miller, S. M. Hammond, D. Anderluzzi, T. D. H. Bugg, J. Chem. Soc. Perkin Trans. 1 1998, 131-142.
49. J. Hiratake, H. Kato, J. Oda, J. Am. Chem. Soc. 1994, 116, 12059-12060.
50. C. Verbruggen, S. De Craecker, P. Rajan, X.-Y. Jiao, M. Borloo, K. Smith, A. H. Fairlamb, A. Haemers, Bioorg. Med. Chem. Lett. 1996, 6, 253-258.
51. C.-H. Lin, S. Chen, D. S. Kwon, J. K. Coward, C. T. Walsh, Chem. Biol. 1997, 4, 859-866.
52. J.-M. Campagne, J. Coste, L. Guillou, A. Heitz, P. Jouin, Tetrahedron Lett. 1993, 34, 4181-4184.
53. A. Yiotakis, S. Vassiliou, J. Jirácek, V. Dive, J. Org. Chem. 1996, 61, 6601-6605.
54. P. H. Dorff, G. Chiu, S. W. Goldstein, B. P. Morgan, Tetrahedron Lett. 1998, 39, 3375-3378.
55. J. S. Früchtel, G. Jung, Angew. Chem. 1996, 108, 19-46; Angew. Chem. Int. Ed. Engl. 1996, 35, 17-42.
56. J. S. Früchtel, G. Jung, Angew. Chem. 1996, 108, 19-46; Angew. Chem. Int. Ed. Engl. 1996, 35, 17-42.
57. 2): 3-nitrotyrosine.
58. H. Stetter, H. Kuhlmann, Synthesis 1979, 29-30.
59. E. K. Baylis, C. D. Campbell, J. G. Dingwall, J. Chem. Soc. Perkin Trans. 1 1984, 2845-2853.
60. X.-Y. Jiao, C. Verbruggen, M. Borloo, W. Bollaert, A. De Groot, R. Dommisse, A. Haemers, Synthesis 1994, 23-24.
61. J. G. Dingwall, J. Ehrenfreund, R. G. Hall, Tetrahedron 1989, 45, 3787-3808.
62. P. P. McCleery, B. Tuck, J. Chem. Soc. Perkin Trans. 1 1989, 1319-1329.
63. M. J. Gallagher, H. Honegger, Tetrahedron Lett. 1977, 34, 2987-2990.
64. M. J. Gallagher, H. Honegger, Aust. J. Chem. 1980, 33, 287-294.
65. P. E. Maligres, I. Houpis, K. Rossen, A. Molina, J. Sager, V. Upadhyay, K. M. Wells, R. A. Reamer, J. E. Lynch, D. Askin, R. P. Volante, P. J. Reider, Tetrahedron 1997, 53, 10983-10992.
66. D. E. C. Corbridge, Phosphorus: An Outline of Its Chemistry, Biochemistry, and Technology, 4th ed., Elsevier, Amsterdam, 1990.
67. E. A. Boyd, A. C. Regan, K. James, Tetrahedron Lett. 1992, 33, 813-816.
68. W. P. Malachowski, J. K. Coward, J. Org. Chem. 1994, 59, 7625-7634.
69. R. S. Rogers, Tetrahedron Lett. 1992, 33, 7473-7474.
70. F. Cramer, K. Pawelzik, H. J. Baldauf, Chem. Ber. 1958, 91, 1049-1054.
71. T. W. Greene, P. G. M. Wuts, Protective Groups in Organic Synthesis, 2nd ed., John Wiley and Sons, New York, 1991.
72. M. Meldal, I. Svendsen, K. Breddam, F.-I. Auzanneau, Proc. Natl. Acad. Sci. USA 1994, 91, 3314-3318.
73. E. Atherton, R. C. Sheppard, Solid-Phase Peptide Synthesis: A Practical Approach, IRL Press, Oxford, 1989.
74. F.-I. Auzanneau, M. Meldal, K. Bock, J. Pept. Sci. 1995, 1, 31-44.
75. R. Knorr, A. Trzeciak, W. Bannwarth, D. Gillesen, Tetrahedron Lett. 1989, 30, 1927-1930.
76. S. A. Watson, Cancer Res. 1995, 55, 3629-3633.
77. J. L. Seltzer, H. Weingarten, K. T. Akers, M. L. Eschbach, G. A. Grant, A. Z. Eisen, J. Biol. Chem. 1989, 264, 19583-19586.
78. M. Meldal, I. Svendsen, J. Chem. Soc. Perkin Trans. 1 1995, 1591-1596.
79. N. M. Target, J. P. Kilcoyne, B. Green, J. Org. Chem. 1979, 44, 4962-4964.
80. The synthesis of 2a involves the use of the pentavalent hypophosphorus acid derivative, ethyl (diethoxymethyl)phosphinate. Anhydrous hypophosphorus acid is reported to be required for the preparation of this compound, but we observed that explosive substances were formed in this reaction when hypophosphorus acid containing less than 5% water was used (rigorously dried by coevaporation several times with 1,4-dioxane below RT). Instead, 95% aqueous hypophosphorus acid obtained by simple rotary evaporation of the commercial 50% acid at high vacuum was found to be sufficient for this purpose.
81. f values given here are mean values for the two spots.
82. B. Blankemeyer-Menge, M. Nimtz, R. Frank, Tetrahedron Lett. 1990, 37, 1701-1704.
83. The BHK cell line was purchased from University Technologies International Inc., Calgary University, Calgary, Canada.